Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrathiomolybdate in Hepatocellular Carcinoma
NCT00006332Phase 2Completed
- Sponsor
- National Center for Research Resources
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tetrathiomolybdate in hepatocellular carcinoma (HCC), sponsored by National Center for Research Resources. Primary endpoint: Tumor Progression at 1 year. Status: completed.
02
Drugs
tetrathiomolybdate
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00006332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006332.